Showing results (351-360 of 384) with videos related to
Sort By:
Pageof 39
Clinical Chemistry|October 15, 2011
Fifth-generation digital immunoassay for prostate-specific antigen by single molecule array technologyDavid H Wilson, David W Hanlon, Gail K Provuncher, et al.The Prostate|March 29, 2023
Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profileVictor R Adorno Febles, Yuan Hao, Aarif Ahsan, et al.Journal of the National Cancer Institute|August 12, 2025
Prostate Cancer Imaging Stewardship: a multi-modal, physician-centered intervention for guideline-concordant imagingDanil V Makarov, Jerry K Thomas, Shannon Ciprut, et al.Implementation Science Communications|April 9, 2024
Unpacking overuse of androgen deprivation therapy for prostate cancer to inform de-implementation strategiesTed A Skolarus, Sarah T Hawley, Jane Forman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Association of prostate cancer risk variants with clinicopathologic characteristics of the diseaseJianfeng Xu, Sarah D Isaacs, Jielin Sun, et al.The Journal of Urology|April 22, 2014
Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsiesAlan W Partin, Leander Van Neste, Eric A Klein, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Phase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkersEmmanuel S Antonarakis, Elisabeth I Heath, Janet R Walczak, et al.Plos One|February 17, 2021
Feasibility of integrating canine olfaction with chemical and microbial profiling of urine to detect lethal prostate cancerClaire Guest, Rob Harris, Karen S Sfanos, et al.The Journal of Urology|August 25, 2022
Cell Cycle Progression Score, but Not Phosphatase and Tensin Homolog Loss, Is an Independent Prognostic Factor for Metastasis in Intermediate- and High-risk Prostate Cancer in Men Treated With and Without Salvage RadiotherapyBruce J Trock, Yuezhou Jing, Brent Mabey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2014
Can urinary PCA3 supplement PSA in the early detection of prostate cancer?John T Wei, Ziding Feng, Alan W Partin, et al.Pageof 39